Page last updated: 2024-09-05

enzastaurin and Stomach Neoplasms

enzastaurin has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bang, YJ; Choi, HJ; Im, SA; Kang, BC; Kim, HP; Kim, SG; Kim, TY; Kim, WH; Kwon, E; Lee, KW; Park, JH; You, J1

Other Studies

1 other study(ies) available for enzastaurin and Stomach Neoplasms

ArticleYear
Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Cancer research, 2008, Mar-15, Volume: 68, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-Associated Death Protein; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Indoles; Mice; Mice, Nude; Mitochondria; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Stomach Neoplasms; Xenograft Model Antitumor Assays

2008